Sociedad Americana de Hirudoterapia

Treatment Protocol for Compromised Nasal Skin

Research article published in Facial plastic surgery clinics of North America (2019)

Última actualización: March 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Ensayos clínicosKerolus J, Nassif P · Facial plastic surgery clinics of North America, 2019

Abstract

As the number of patients seeking surgical and nonsurgical rhinoplasty continues to increase, the risk of nasal skin compromise after surgery also has risen. Vascular insult to the nasal skin envelope can lead to permanent disfigurement that is nearly impossible to correct. Tissue loss often requires major reconstruction that yields suboptimal cosmetic results. This article discusses prevention, early recognition, and effective treatment that aim to mitigate skin necrosis and the resulting soft tissue destruction.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleReview
Indexed MeSH termsAdministration, CutaneousAnti-Bacterial AgentsHumansHyperbaric OxygenationLeechingNecrosisNitroglycerinNosePostoperative ComplicationsRhinoplastyRisk FactorsSkin

Resumen

As the number of patients seeking surgical and nonsurgical rhinoplasty continues to increase, the risk of nasal skin compromise after surgery also has risen.

Por qué esto importa para la hirudoterapia

Contributes clinical evidence for the therapeutic application of leech therapy.

Citación

Treatment Protocol for Compromised Nasal Skin.

Kerolus J, Nassif P · Facial plastic surgery clinics of North America, 2019

Contexto clínico relacionado

Explore cómo esta investigación se conecta con la práctica clínica

Añadido a la biblioteca ASH: March 18, 2026 · Última actualización del sitio: March 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.

Treatment Protocol for Compromised Nasal Skin | ASH